Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design, , , , , , and . Viruses, 7 (7): 3995-4046 (2015)Clinical course of infection and viral tissue tropism of hepatitis C virus-like non-primate hepaciviruses in horses, , , , , , , , , and 7 other author(s). Hepatology, 61 (2): 448-459 (2015)Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells, , , , , , , , , and 4 other author(s). Hepatology, 59 (1): 78-88 (2014)Root of the universal tree of life based on ancient aminoacyl-tRNA synthetase gene duplications, and . Proc. Natl. Acad. Sci., (1995)Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region, , , , , , , , , and . Antiviral Res, (2014)Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells, , , , , , , , , and 6 other author(s). Gut, 63 (7): 1137-1149 (2014)Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells, , , , , , , , , and 4 other author(s). Hepatology, 59 (1): 78-88 (2014)Hepaciviral NS3/4A proteases interfere with MAVS signalling of their cognate animal hosts and also with human MAVS: implications for zoonotic transmission, , , , , , and . J Virol, 90 (23): 10670-10681 (2016)Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells, , , , , , , , , and 6 other author(s). Gut, 63 (7): 1137-1149 (2014)Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice, , , , , , , , , and 8 other author(s). Gut, 65 (12): 2029-2034 (2016)